ABSTRACT
tissue possible with the maximal preservation of the gland function 8 . The best approach is transseptal transsphenoidal surgery; however, craniotomy or endoscopic surgery may be performed depending on the topography and characteristics of the lesion 8, 9 .
Materials and Methods
Using the databases PubMed, MedLine, and Scielo, we searched for the key words "pituitary adenoma" and "postoperative" and were obtained 760 results analyzing articles published between January 2007 and December 2016. In addition, 11 studies were obtained by analyzing the titles and abstracts written in English and Portuguese, which evaluated the hormonal complications in the postoperative period of pituitary adenomas resection. All included studies were retrospective, with the exception of Cooper et al. 10 in a cohort study. This study does not describe the surgical approach used. In Mello et al. 4 , 8% of the patients had a transcranial approach, and Kim et al. 11 found that 95.9% of the patients had a transsphenoidal approach, which was used in the other studies.
Results
Among the 1166 patients studied by Wang et al. 1 , 1.29% presented hypopituitarism after surgery. Among the 73 patients evaluated by Kim et al. 11, 60 .3% presented hypopituitarism after surgery and used hormone replacement with levothyroxine and/or hydrocortisone.
Among the 11 studies analyzed, 7 presented the occurrence of pituitary adenomas according to the hormonal classification of tumors (Table 1) , 5 addressed the prevalence of preoperative deficits, and 6 studies presented the rates of postoperative complications of adenomas (Tables 2 and 3 , respectively).
Yamada et al.

Introduction
Pituitary adenomas are benign tumors that occur in the adenohypophysis and intracranial tumors are the most frequent 1, 2 . They are mainly classified into functioning and nonfunctioning adenomas and macroadenomas (diameter larger than 10mm) and microadenomas (diameter smaller than 10 mm) 2, 3 .
The nonfunctioning tumors initially present atypical clinical picture, which may demonstrate less hormonal production or production of peptides without biological action in the immunohistochemistry. Usually, the diagnosis is late and showing with large lesions. The main signs and symptoms result from the compression of adjacent structures such as the optic chiasm or the destruction of pituitary cells, which cause variable decreases in hormonal secretion 1, 4 . The tumors rarely produce subunits of glycopeptide hormones (TSH, FSH) or inactive forms (ACTH, GH). Gonadotrophic adenomas are within the group of nonfunctioning tumors and occur predominantly in the elderly (although they are secretors), which makes the symptoms imperceptible 2 .
Functioning tumors present a clinical picture according to the affected hormonal axis and can be: secretors of GH (somatotrophinomas), which is the most common cause of acromegaly; secretors of prolactin (prolactinomas), which present a clinical picture of amenorrhea and galactorrhea in women and present low libido and impotence in men 2 ; secretors of ACTH (corticotrophinomas), which generate excessive cortisol and promote clinical alterations known as Cushing's syndrome 2 ; secretors of TSH (thyrotropinomas), which present a clinical picture of hyperthyroidism. Functioning tumors can also cause pituitary apoplexy due to ischemia or hemorrhage in the gland 5 .
For the diagnosis of tumors, MRI is the imaging method of choice to evaluate the pituitary and sellar region 6 . The tumors present a signal lower than the parenchyma in T1, and the signal in T2 is variable; the use of contrast helps the diagnosis of lesions which is not clearly evident in T1 without contrast, mainly in Cushing's syndrome 7 .
The first-line treatment is surgery, except in cases of microadenomas that are secretors of prolactin (in this case, dopamine agonists should be used) 3, 6, 8 . The main objective of resection of pituitary tumors is the maximum removal of tumor Krzentowska-Korek et al. 12 evaluated 85 patients presenting acromegaly, with 77.6% macroadenomas and 22.4% microadenomas. The postoperative occurrence of diabetes insipidus was 16.7% and 22.2%, respectively. Among the 45 patients with complete evaluation of the hormonal axes, 73.3% had normal function before surgery and 21.2% had hypopituitarism; the adrenal axis was the most affected. Among those with hypopituitarism, 50% had functions restored, 41.7% had their clinical picture worsened, and 8.3% did not have changes.
Discussion
The incidence rate of pituitary adenomas varies according to the reference. Based on the analyzed studies, in general, nonfunctioning tumors are more frequent and present hypopituitarism, which affected the gonadotrophic axis from 30.8% to 72.6% 4, 10, 13 . Among the functioning adenomas, prolactinomas are more common, followed by somatotrophinomas, corticotrophinomas and, finally, thyrotrophinomas 1, 8, 11 ; the exception occurred in the study by Barbosa et al. 9 . None of the articles showed the incidence rate in the study population of gonadotrophinomas. GH secretory tumors are the most common cause of acromegaly 12 , which presents excessive somatic growth and systemic complications; gigantism can occur in children and adolescents 2, 12 . In the observed studies, 26.7% to 35.5% 9, 12 of the patients with acromegaly had preoperative hormonal deficiencies; the most common were hypogonadism, followed by central hypothyroidism and panhypopituitarism 9 . In the postoperative period, among those whose function was already deficient, 11.1% to 41.7% of the patients presented worsening, 33.3% to 50% presented normal pituitary function, and 8.33% to 55.6% still presented deficiencies 9, 12 . Among the patients with normal preoperative function, 5% to 21.2% of the patients had hypopituitarism 8, 9, 12 .
Krzwowski-Korek et al. 12 and Marić et al. 8 described that the most affected axis was the adrenal axis; the latter authors reported that hypogonadism was the second most frequent. In addition, Barbosa et al. 9 detected that the alteration presented was central hypothyroidism concomitant with hypogonadism. Hána et al. 15 studied the development of adrenal insufficiency and describe that it did not occur in the patients studied. The incidence of diabetes insipidus ranged from 0% to 12.9% 8, 9 and Krzentowska-Korek et al. 12 reported an incidence of 16.7% in macroadenomas and 22.2% in microadenomas. Considering these data, we noted that there is no consensus on which hormones are most affected in the postoperative period of gonadotrophinomas.
Tumors that secrete prolactin present clinical signs of amenorrhea and galactorrhea in women and decreased libido and impotence in men 2 . Barbosa et al. 9 pointed out that 66.7% of patients with prolactinomas were previously treated had hypopituitarism in the preoperative period; also, they did not present neither new deficiencies nor diabetes insipidus. Other studies 8, 15 demonstrated that 1.6% to 25% of prolactinomas presented adrenal insufficiency in the postoperative period. Only Marić et al. 8 reported an incidence rate of diabetes insipidus of 3.2%.
Tumors that secrete ACTH generate excessive cortisol and promote Cushing's syndrome 2 . This condition, associated with the radiological image compatible with pituitary adenoma or the presence of an ACTH gradient during simultaneous bilateral catheterization of the inferior petrosal sinus, leads to the diagnosis of Cushing's Disease 16 . Corticotrophinomas presented a 50% incidence of amenorrhea or puberty delay; all patients recovered after surgery 9 . In the postoperative period, 28.6% of the patients presented hypothyroidism, 25% presented adrenal insufficiency, and 25% to 28.6% presented diabetes insipidus 8, 9 .
Tumors that secrete TSH present a clinical picture of hyperthyroidism 2 . Among the thyrotrophinomas, Barbosa et al. 9 evaluated only one case, which did not present preoperative deficits and presented central hypothyroidism in the postoperative period. Yamada et al. 3 detected 20% of prolactinomas and 15.6% of concomitant acromegaly. In the postoperative period, most patients presented diabetes insipidus, followed by GH deficiency and panhypopituitarism (Table 4) . 
Conclusion
Hypopituitarism is a frequent complication in patients that underwent pituitary gland surgery due to the compression and destruction of the pituitary gland because of the mass effect; also, it may possibly occur because of the focal necrosis after the compression of the hypophyseal portal system 8 or may even be the result of the surgical manipulation itself. Another common surgical complication is diabetes insipidus, characterized by polyuria with decreased osmolarity and polydipsia (due to the absence of ADH secretion). Minimally invasive surgeries (using transsphenoidal approach, for example) have lower incidence rates 17 .
The reviewed articles allowed us to conclude that nonfunctioning adenomas are more common and present hypopituitarism due to the destruction of pituitary cells; it causes variable decreases in hormonal secretion 1 and considerably affects the gonadotrophic axis 4, 10, 13 . Prolactinomas are the most frequent tumors among functioning adenomas, followed by somatotrophinomas 1, 8, 11 ; the studies presented varied incidence rates probably due to the sample size heterogeneity. We can state that the occurrence of hypopituitarism in the postoperative period ranges from 1.29% to 21.2% and the occurrence of diabetes insipidus from 5.1% to 15.7% 1, 8, 9, 12, 14 .
In somatotrophinomas, the most common complication was not the same in all studies; between 33.3% and 50% of the patients with acromegaly submitted to surgery showed improvement or normalization of the hormonal axis 9, 12 . In prolactinomas, ACTH deficiency was the most common complication 8, 15 . Finally, in corticotrophinomas, hypothyroidism and adrenal insufficiency were the most common complications 8, 9 and there was normalization of menstrual cycles and pubertal development in all patients after surgery 9 .
In thyrotrophinomas, the hypersecretion concomitant with GH and / or prolactin was frequent 9 . Possibly, it is due to the fact that cells that secrete GH and PRL share transcription factors with cells that secrete TSH 3 . In the postoperative period, GH deficiency and panhypopituitarism were the most frequent complications 9 .
